Printer Friendly

COPLEY PHARMACEUTICAL, INC. RESPONDS TO REPORTED LITIGATION

 CANTON, Mass., Nov. 25 ~PRNewswire~ -- Copley Pharmaceutical, Inc. (NASDAQ: CPLY) announced today that it has been informed that both it and the Fermion division of Orion Corp. of Finland were sued by Marion Merrell Dow, Inc. and Tanabe Seiyaku Co. for an alleged violation of Tanabe's U.S. patent rights to a production process for diltiazem, an ingredient in cardiovascular medication sold by both Copley and Marion. The patent on diltiazem itself expired on Nov. 5, 1992. Fermion manufactures and supplies Copley with diltiazem. Copley has not been served with process in connection with any such suit nor received a copy of Marion's and Tanabe's reputed complaint against it and thus remains unable to respond with particularity to any allegations. However, Fermion has assured Copley that the process by which Fermion manufactures diltiazem does not infringe the patent rights claimed by Tanabe. Copley will defend itself vigorously against any infringement charges.
 -0- 11~25~92
 ~CONTACT: Steven N. Tannenbaum, executive vice president-finance of Copley Pharmaceutical, Inc., 617-821-6111~
 (CPLY)


CO: Copley Pharmaceuticals ST: Massachusetts IN: MTC SU:

CH -- NE007 -- 1523 11~25~92 12:59 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 25, 1992
Words:185
Previous Article:LIFECORE SIGNS RESEARCH AGREEMENT WITH IOLAB CORPORATION
Next Article:AMEX YEAR-TO-DATE EQUITY & INDEX OPTIONS VOLUME JUMPS BY NEARLY 15 PERCENT
Topics:


Related Articles
MARION MERRELL DOW ANNOUNCES SETTLEMENT WITH GENERIC MAKER ON LOOK-ALIKE TABLETS
MARION MERRELL DOW AND TANABE SEIYAKU FILE INTERNATIONAL TRADE COMPLAINT AGAINST CARDIZEM IMITATORS
COPLEY PHARMACEUTICAL, INC. ANNOUNCES LITIGATION
COPLEY PHARMACEUTICAL, INC. ANNOUNCES SETTLEMENT OF SHAREHOLDER LITIGATION
COPLEY ANNOUNCES SHAREHOLDER LITIGATION
COPLEY PHARMACEUTICAL, INC. ANNOUNCES SECOND QUARTER RESULTS
Warner-Lambert Files Suit Against Copley
Copley Pharmaceutical, Inc. Announces Cost Reduction Initiatives
Copley Enters Plea
Copley Pharmaceutical Named in Shareholder Derivative Suit

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters